8.40% p.a. Early Redemption Worst of GOAL

Underlying: AstraZeneca / Johnson & Johnson / Merck & Co. SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 53014155 / ISIN: CH0530141552

Last update 07.08.2020
  • Bid

    102.15 %
    Volume: 10'000

  • Ask

    103.15 %
    Volume: 10'000

CurrencyCHF
IssuerUBS AG, London Branch
Settlementphysical
Fixing date11.03.2020
Expiry11.03.2021
Sideways return1.02% / 9.68% p.a.
Unit price1'000.00 CHF
Underlying price1)
AstraZeneca
Johnson & Johnson
Merck & Co.

84.87312 GBP
148.60 USD
81.02 USD
Display
  • Product chart
1) Prices are 15 Min. delayed